AstraZeneca discontinues Elavil
AstraZeneca has discontinued its antidepressant Elavil (amitriptyline). The injection form is no longer available and the tablet inventory is expected to be depleted by the end of the year. The drug, which was manufactured by Merck, was cited for GMP problems in 2000 (1"The Pink Sheet" July 17, 2000, p. 24)...
You may also be interested in...
Inadequate sampling, testing, investigation and documentation of Merck's Vioxx (rofecoxib) lots are among good manufacturing practice violations cited in a June 27 FDA warning letter.
Abbott is encouraged by results from two studies of its Proclaim XR neurostimulation system for chronic pain, presented at the annual North American Neuromodulation Society (NANS) meeting in Las Vegas. See what Steven Falowski of Neurosurgical Associates of Lancester in Pennsylvania said about it here.
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.